Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $6.2 million.

  • TransMedics' Other Working Capital Changes rose 11751.49% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 1637.49%. This contributed to the annual value of $1654.0 for FY2024, which is 7652.08% up from last year.
  • Per TransMedics' latest filing, its Other Working Capital Changes stood at $6.2 million for Q3 2025, which was up 11751.49% from $550000.0 recorded in Q2 2025.
  • TransMedics' 5-year Other Working Capital Changes high stood at $6.2 million for Q3 2025, and its period low was -$3.1 million during Q4 2022.
  • Its 5-year average for Other Working Capital Changes is $726947.4, with a median of $550000.0 in 2025.
  • In the last 5 years, TransMedics' Other Working Capital Changes surged by 65666.67% in 2021 and then crashed by 174772.73% in 2023.
  • Quarter analysis of 5 years shows TransMedics' Other Working Capital Changes stood at $1.8 million in 2021, then tumbled by 276.86% to -$3.1 million in 2022, then soared by 97.78% to -$69000.0 in 2023, then skyrocketed by 384.06% to $196000.0 in 2024, then skyrocketed by 3061.73% to $6.2 million in 2025.
  • Its Other Working Capital Changes stands at $6.2 million for Q3 2025, versus $550000.0 for Q2 2025 and -$1.9 million for Q1 2025.